Resverlogix

Resverlogix RVXCF Stock

$0.05   0.000000%
Add to favorites
Market Cap
$17.21M
LOW - HIGH [24H]
$0.06 - $0.06
VOLUME [24H]
$3.00K
P/E Ratio
0
Earnings per share
-$0.03
ISIN
CA76128M1086

Resverlogix Price Chart

Sorry, that's all we've gotfor now...

Resverlogix (RVXCF) stock price today is 0.05 USD on OTC Markets OTCPK (0% on the day). Updated .

Resverlogix RVXCF Financial and Trading Overview

Resverlogix stock price 0.05 USD
Previous Close 0.05 USD
Open 0.06 USD
Bid 0.05 USD x 10000000
Ask 0.07 USD x 2500000
Day's Range 0.06 - 0.06 USD
52 Week Range 0.04 - 0.1 USD
Volume 3K USD
Avg. Volume 12.38K USD
Market Cap 17.21M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

RVXCF Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Resverlogix Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -37.50%
S&P500 52-Week Change 8.67%
52 Week High 0.1 USD
52 Week Low 0.04 USD
50-Day Moving Average 0.06 USD
200-Day Moving Average 0.07 USD

RVXCF Share Statistics

Avg. Volume (3 month) 12.38K USD
Avg. Daily Volume (10-Days) 21.81K USD
Shares Outstanding 344.29M
Float N/A
Short Ratio N/A
% Held by Insiders 26.36%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) N/A
Book Value Per Share (mrq) -0.309

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Resverlogix

Country United States
State AB
City Calgary
Address 4820 Richard Road SW
ZIP T3E 6L1
Phone 403 254 9252
Website https://www.resverlogix.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID-19 conditions. The company has a partnership with Eversana Life Science Services, LLC to support the commercialization of apabetalone for COVID-19 in the United States and Canada; developing cardiovascular and pulmonary arterial hypertension indications; and Medison Pharma Ltd. The company is headquartered in Calgary, Canada.

Q&A For Resverlogix Stock

What is a current RVXCF stock price?

Resverlogix RVXCF stock price today per share is 0.05 USD.

How to purchase Resverlogix stock?

You can buy RVXCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Resverlogix?

The stock symbol or ticker of Resverlogix is RVXCF.

Which industry does the Resverlogix company belong to?

The Resverlogix industry is Biotechnology.

How many shares does Resverlogix have in circulation?

The max supply of Resverlogix shares is 344.29M.

What is Resverlogix Price to Earnings Ratio (PE Ratio)?

Resverlogix PE Ratio is now.

What was Resverlogix earnings per share over the trailing 12 months (TTM)?

Resverlogix EPS is -0.03 USD over the trailing 12 months.

Which sector does the Resverlogix company belong to?

The Resverlogix sector is Healthcare.

$2.09T
Total marketcap
$111.61B
Total volume
BTC 57.93%   •   ETH 9.83%
Dominance
Select currency